MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for TremfyaR OnePress PatientControlled Injector for Adults with ModeratetoSevere Plaque Psoriasis news with additional features

DGAPNews MorphoSys AG Key words Miscellaneous27.02.2019 1359 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany February 27 2019 MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tre...